{"created":"2023-07-07T02:15:52.960399+00:00","id":2019914,"links":{},"metadata":{"_buckets":{"deposit":"f1b432c9-ac54-4994-b456-3fda0ab547d1"},"_deposit":{"created_by":8,"id":"2019914","owner":"8","owners":[8],"pid":{"revision_id":0,"type":"depid","value":"2019914"},"status":"published"},"_oai":{"id":"oai:u-ryukyu.repo.nii.ac.jp:02019914","sets":["1642838163960:1642838338003","1642838403551:1642838409905"]},"author_link":[],"item_1617186331708":{"attribute_name":"Title","attribute_value_mlt":[{"subitem_title":"Changes in psychotropic polypharmacy and high-potency prescription following policy change: Findings from a large scale Japanese claims database","subitem_title_language":"en"}]},"item_1617186419668":{"attribute_name":"Creator","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"Takeshima, Masahiro","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"Enomoto, Minori","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"Ogasawara, Masaya","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"Kudo, Mizuki","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"Itoh, Yu","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"Yoshizawa, Kazuhisa","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"Fujiwara, Dai","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"Takaesu, Yoshikazu","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"Mishima, Kazuo","creatorNameLang":"en"}]}]},"item_1617186476635":{"attribute_name":"Access Rights","attribute_value_mlt":[{"subitem_access_right":"open access","subitem_access_right_uri":"http://purl.org/coar/access_right/c_abf2"}]},"item_1617186499011":{"attribute_name":"Rights","attribute_value_mlt":[{"subitem_rights":"© 2022 The Authors.Psychiatry and Clinical Neurosciences published by John Wiley & Sons Australia, Ltd on behalf of Japanese Society of Psychiatry and Neurology.","subitem_rights_language":"en"},{"subitem_rights":"This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.","subitem_rights_language":"en","subitem_rights_resource":"https://creativecommons.org/licenses/by/4.0/"}]},"item_1617186643794":{"attribute_name":"Publisher","attribute_value_mlt":[{"subitem_publisher":"© 2022 The Authors.Psychiatry and Clinical Neurosciences published by John Wiley & Sons Australia, Ltd on behalf of Japanese Society of Psychiatry and Neurology.","subitem_publisher_language":"en"}]},"item_1617186702042":{"attribute_name":"Language","attribute_value_mlt":[{"subitem_language":"eng"}]},"item_1617186920753":{"attribute_name":"Source Identifier","attribute_value_mlt":[{"subitem_source_identifier":"1440-1819","subitem_source_identifier_type":"EISSN"}]},"item_1617186941041":{"attribute_name":"Source Title","attribute_value_mlt":[{"subitem_source_title":"Psychiatry and Clinical Neurosciences","subitem_source_title_language":"en"}]},"item_1617187056579":{"attribute_name":"Bibliographic Information","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2022-06-02","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"9","bibliographicPageEnd":"477","bibliographicPageStart":"475","bibliographicVolumeNumber":"76"}]},"item_1617258105262":{"attribute_name":"Resource Type","attribute_value_mlt":[{"resourcetype":"journal article","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_1617265215918":{"attribute_name":"Version Type","attribute_value_mlt":[{"subitem_version_resource":"http://purl.org/coar/version/c_970fb48d4fbd8a85","subitem_version_type":"VoR"}]},"item_1617353299429":{"attribute_name":"Relation","attribute_value_mlt":[{"subitem_relation_type_id":{"subitem_relation_type_id_text":"https://doi.org/10.1111/pcn.13432","subitem_relation_type_select":"DOI"}}]},"item_1617605131499":{"attribute_name":"File","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_access","date":[{"dateType":"Available","dateValue":"2023-07-07"}],"filename":"Psychiatry Clin Neurosci - 2022 - Takeshima - Changes in psychotropic polypharmacy and high‐potency prescription following.pdf","filesize":[{"value":"190 KB"}],"url":{"url":"https://u-ryukyu.repo.nii.ac.jp/record/2019914/files/Psychiatry Clin Neurosci - 2022 - Takeshima - Changes in psychotropic polypharmacy and high‐potency prescription following.pdf"},"version_id":"612e3cb7-f300-45e3-8412-f20975d555bd"}]},"item_title":"Changes in psychotropic polypharmacy and high-potency prescription following policy change: Findings from a large scale Japanese claims database","item_type_id":"59","owner":"8","path":["1642838338003","1642838409905"],"pubdate":{"attribute_name":"PubDate","attribute_value":"2023-07-07"},"publish_date":"2023-07-07","publish_status":"0","recid":"2019914","relation_version_is_last":true,"title":["Changes in psychotropic polypharmacy and high-potency prescription following policy change: Findings from a large scale Japanese claims database"],"weko_creator_id":"8","weko_shared_id":-1},"updated":"2023-08-03T05:44:52.314513+00:00"}